GHRP-6 vs Hexarelin
Side-by-side comparison of GHRP-6, Hexarelin — mechanism, dosing, half-life, side effects, and research status.
| Attribute | GHRP-6 Growth Hormone Releasing Peptide-6 Growth Hormone | Hexarelin Hexarelin (Examorelin) Growth Hormone |
|---|---|---|
| Basics | ||
| Molecular type | Growth Hormone Releasing Peptide (GHRP) | Growth Hormone Releasing Peptide (GHRP) |
| Amino acids | 6 | 6 |
| Molecular weight | 873.0 Da | 887.1 Da |
| Half-life | ~15–60 min | ~2 hours |
| Route(s) | Subcutaneous, Intramuscular, Intranasal | Subcutaneous, Intramuscular, Intranasal |
| Mechanism & Research | ||
| Primary mechanism | GHRP-6 activates ghrelin receptors (GHSR-1a) in both the hypothalamus and pituitary. Hypothalamic activation reduces somatostatin release (enabling larger GH pulses) and strongly activates appetite pathways — explaining … | Hexarelin activates GHSR-1a with exceptionally high potency, producing GH pulse amplitudes that exceed GHRP-2 and GHRP-6 at equivalent doses. It also acts at the hypothalamic level to suppress somatostatin, contributing … |
| Research status | Research Compound | Research Compound |
| Evidence summary | GHRP-6 was one of the earliest compounds to enter GHRP clinical research, with human trials dating to the early 1990s. It has been used as a reference compound for characterising GHRP biology and ghrelin receptor pharmac… | Hexarelin has Phase 1/2 clinical data including cardiac research. Its direct cardioprotective mechanism is one of the most distinctive features of any GHRP. Research also supports its use in GH deficiency testing. |
| Protocol & Dosing | ||
| Typical dose | 100–300 mcg per injection | 100–200 mcg per injection |
| Frequency | 2–3× daily | 2× daily |
| Duration | 8–12 weeks | 4–6 weeks maximum (desensitisation concern) |
| Timing | Fasted state or 2+ hours post-meal | Fasted state |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Prohibited (WADA S2) | Prohibited (WADA S2) |
| Deeper reading | ||
| Related peptides | Ipamorelin, GHRP-2, Hexarelin, CJC-1295 | GHRP-2, GHRP-6, Ipamorelin |
| Full profile | Read full GHRP-6 profile → | Read full Hexarelin profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.